U.S. biotech firm Monsanto said on Tuesday it does not plan to sell its genetically modified maize MON810 in France this year, nor after, even though the country’s highest court overturned a 3-year ban in November. “Monsanto considers that favorable conditions for the sale of the MON810 in France in 2012 and beyond are not in place,” the company said in a statement, adding that it had told the French authorities about its intentions.